Kite Pharma Investors
Kite Pharma is an innovative biotechnology company based in Los Angeles, California, founded in 2009 The company specializes in the development of cancer immunotherapy treatments, particularly focusing on engineered autologous cell therapy Kite Pharma has successfully raised a total of $127 million in investments to support its research and development initiatives The firm is committed to advancing the field of oncology through its cutting-edge therapies and has made significant contributions to the treatment of hematologic malignancies With a strong emphasis on scientific excellence, Kite Pharma aims to improve patient outcomes and enhance the quality of life for those affected by cancer
%20.jpg)
Acquisitions Number:
Made Acquisitions, Was Acquired
Founded Date:
2009
Last Funding Type:
Convertible Note
Headquarters:
USA
Investors Number:
11
Technology:
['BioTech & HealthTech']
Employee Number:
101-250
Industry:
FemTech
Estimated Revenue:
$10B+
Last Funding Date:
2015-12-10
Number Of Exists:
1
Funding Status:
M&A
Investor Type:
Angel Groups
Total Funding:
22322058